Results 111 to 120 of about 5,643 (237)

A comprehensive genomic study of 390 H3F3A‑mutant pediatric and adult difuse high‑grade gliomas, CNS WHO grade 4 [PDF]

open access: yes
Malignant brain tumors, known as H3K27-altered diffuse midline glioma (DMG) and H3G34-mutant diffuse hemispheric glioma (DHG), can affect individuals of all ages and are classified as CNS WHO grade 4.
Brastianos, Priscilla K.   +7 more
core   +2 more sources

DIPG-64. UNRAVELING H3K27M INTERACTIONS IN DIFFUSE MIDLINE GLIOMA

open access: yesNeuro-Oncology
Abstract BACKGROUND Diffuse midline glioma (DMG) harboring the histone H3 K27M mutation, also known as diffuse intrinsic pontine glioma when it occurs in the pons, is a uniformly fatal pediatric brain tumor. We sought to better understand protein-protein interactions of the mutant histone in DMG.
Liapodimitri, Athanasia   +6 more
openaire   +1 more source

A pineal mass in a 39‐year‐old woman

open access: yes
Brain Pathology, Volume 35, Issue 5, September 2025.
Charlotte Paoli   +5 more
wiley   +1 more source

H3.1K27M-induced misregulation of the TONSOKU-H3.1 pathway causes genomic instability

open access: yesNature Communications
The oncomutation lysine 27-to-methionine in histone H3 (H3K27M) is frequently identified in tumors of patients with diffuse midline glioma-H3K27 altered (DMG-H3K27a).
Wenxin Yuan   +10 more
doaj   +1 more source

Emerging roles of cancer-associated histone mutations in genomic instabilities

open access: yesFrontiers in Cell and Developmental Biology
Epigenetic mechanisms often fuel the quick evolution of cancer cells from normal cells. Mutations or aberrant expressions in the enzymes of DNA methylation, histone post-translational modifications, and chromatin remodellers have been extensively ...
Priyanka Yadav   +2 more
doaj   +1 more source

Table S9 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

open access: gold, 2023
Sriram Venneti   +83 more
openalex   +1 more source

EZHIP's role in diffuse midline glioma: echoes of oncohistones? [PDF]

open access: yes
The enhancer of zeste inhibitory protein (EZHIP) is typically expressed during germ cell development and has been classified as a cancer-testis antigen (CTA) in various cancers.
Cassim, A   +3 more
core   +1 more source

HGG-19. CLINICAL RESPONSE TO THE PDGFRA/KIT INHIBITOR AVAPRITINIB IN PEDIATRIC AND YOUNG ADULT HIGH-GRADE GLIOMA PATIENTS WITH H3K27M OR PDGFRA GENOMIC ALTERATIONS [PDF]

open access: hybrid, 2023
Maria Trissal   +49 more
openalex   +1 more source

H3K27M-mutant, hemispheric diffuse glioma in an adult patient with prolonged survival

open access: gold, 2021
Noel Chia   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy